Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001460956 | SCV001664840 | likely benign | Retinoblastoma | 2023-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160867 | SCV003870853 | likely benign | Hereditary cancer-predisposing syndrome | 2023-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001460956 | SCV004844680 | likely benign | Retinoblastoma | 2023-04-27 | criteria provided, single submitter | clinical testing |